Inhibition of Protein Misfolding and Aggregation by Small Rationally-Designed Peptides
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2557-2567
Author(s):
L. D. Estrada and C. Soto
Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2701-2720
Author(s):
Raphael M. Bonelli and Gregor K. Wenning
Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
237-243
Author(s):
Stefano Zoccolella, Davide Martino, Giovanni Defazio, Paolo Lamberti and Paolo Livrea
Editorial [Hot Topic:Ion Channels as a Target for Drug Design (Executive Editor: Kwok-Keung Tai)]
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2187-2187
Author(s):
Kwok-Keung Tai
Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome
Journal:
Current Pharmacogenomics
Volume:
4
Page:
113-119
Author(s):
Chiaki Kawanishi, Ikuko Kishida, Taku Furuno, Daiji Kato and Leif Bertilsson
Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Journal:
Recent Patents on Cardiovascular Drug Discovery
Volume:
1
Page:
211-224
Author(s):
Gregory J. Chen and Reza Forough
Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
1
Page:
207-217
Author(s):
Rafael Rodriguez-Puertas and Gabriel Barreda-Gomez
Patent Annotations
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
1
Page:
231-234
Author(s):
Autoantibodies Associated with Psychiatric Disorders
Journal:
Current Neurovascular Research
Volume:
3
Page:
149-157
Author(s):
Paola Margutti, Federica Delunardo and Elena Ortona
A Review of Developments in Brain Stimulation and the Treatment of Psychiatric Disorders
Journal:
Current Psychiatry Reviews
Volume:
2
Page:
199-205
Author(s):
Paul B. Fitzgerald